RE:News before the ThinkEquity conference?"There currently appears to be zero or a negative value assigned to this clinical trial by the market; yet the $400 million annual market opportunity is considerable."
So if their beta glucan pill is successful, what will the revenue stream look like. 400 million market opportunity-cost of product-partner etc... x 1 year. Anyone care to take a wild guess?